Vogt-小柳-原田病合并白内障超声乳化手术的预后与影响因素
该回顾性干预病例系列分析了VKH病合并白内障患者超声乳化联合IOL植入的视力结局与预后因素。炎症完全控制至少3个月后手术与 control 后1个月手术在并发症和BCVA上无差异,405眼(99.3%)视力改善。术前BCVA、发病后治疗延迟、术前高眼压、虹膜粘连及术前ERG异常与最终视力相关。
要点
- VKH患者炎症静息眼行超声乳化IOL植入安全有效,炎症控制后1个月手术与3个月手术结局无差异。
- 术前BCVA、治疗延迟、术前高眼压、虹膜粘连及术前ERG异常与术后最终视力相关。
- 术后视力差的主要原因包括视神经萎缩、脉络膜视网膜新生血管和视网膜下纤维化。
核心结论
- VKH病患者在炎症静息眼行超声乳化联合IOL植入可安全成功完成,即使炎症控制后1个月手术亦无并发症或BCVA差异。
- 最终视力预后与术前BCVA、发病后治疗延迟、术前高眼压、虹膜粘连及术前ERG异常相关。
研究设计与样本
- 352眼在眼内炎症完全控制至少3个月后手术,另56眼在炎症控制后1个月手术。
主要发现
- 术后主要并发症为前房积血、眼压升高和中度前房反应。
- 术前平均视力0.08,末次随访时405眼(99.3%)BCVA改善。
- 术后炎症、IOL类型及眼外VKH表现不影响最终BCVA。
- 视力差由视神经萎缩、脉络膜视网膜新生血管和视网膜下纤维化导致。
关键数值与推荐
- 炎症完全控制至少3个月后手术组与炎症控制后1个月手术组在术后并发症和BCVA上无差异。
- 术前BCVA、治疗延迟、术前高眼压、虹膜粘连及术前ERG异常与最终视力结局相关。
临床怎么用
- VKH合并白内障患者可在眼内炎症静息后行超声乳化IOL植入,炎症控制后1个月手术亦属安全。
- 术前应评估BCVA、眼压、虹膜粘连及ERG,以预判视力预后并指导手术时机。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: To investigate visual outcome and prognostic factors following cataract surgery in patients with Vogt-Koyanagi-Harada (VKH) disease. DESIGN: Retrospective, interventional case series. METHODS: The history, clinical characteristics, best-corrected visual acuity (BCVA), full-field electroretinogram (ERG), intraocular inflammation, complications, and extraocular manifestations were analyzed retrospectively. RESULTS: One hundred and forty-eight male (214 eyes) and 138 female (194 eyes) VKH patients with complicated cataract were included. Surgery was performed on 352 eyes after complete control of intraocular inflammation for at least 3 months. In another set of 56 eyes, surgery was done 1 month after intraocular inflammation control. There was no difference in postoperative complications or BCVA between these 2 groups. The main complications after surgery were hyphema, ocular hypertension, and moderate anterior chamber reaction. Average preoperative visual acuity was 0.08. At last visit, BCVA was improved in 405 eyes (99.3%). The preoperative BCVA, treatment delay after disease onset, preoperative intraocular hypertension, and iris synechiae were associated with final visual outcome. Other parameters such as postoperative inflammation, IOL type, and presence of extraocular VKH features did not affect final BCVA. Poor visual acuity was caused by optic nerve atrophy, choroidoretinal neovascularization, and subretinal fibrosis. Poor postoperative BCVA was associated with an abnormal preoperative ERG profile. CONCLUSIONS: Phacoemulsification and IOL implantation in VKH patients can be safely and successfully performed in quiet eyes even after 1 month following the last signs of inflammation. Visual prognosis was associated with preoperative BCVA, treatment delay after disease onset, preoperative intraocular hypertension, iris synechiae, and presence of preoperative ERG abnormalities.
引用
- Ji Y, Hu K, Li C, et al. Outcome and Prognostic Factors of Phacoemulsification Cataract Surgery in Vogt-Koyanagi-Harada Uveitis. Am J Ophthalmol. 2018. PMID: 30194930. doi:10.1016/j.ajo.2018.08.041
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。